TY  - CONF 
AU  - Debén Ariznavarreta, Guillermo
PY  - 2012
SN  - 0006-4971
UR  - http://hdl.handle.net/20.500.11940/7582
LA  - eng
TI  - Assessment of minimal residual disease levels in b-cll after front-line treatment with fc-r and rituximab maintenance
VL  - 120 (21)
ER  -